Inflammation mediates individual differences in risk and resilience to
stress-induced depression. Individual differences in the response to stress (via
gene × environment interactions) predict risk or resilience to the
development of stress-induced behavioral changes. Inflammation has been shown in
animal studies to be a pivotal causative factor of these individual differences.
Animals who exhibit poor coping strategies exhibit exaggerated inflammatory
responses (release of inflammatory cytokines, shift toward M1 macrophage
phenotype, and activation of microglia) and are at risk for the development of
depressive-like behavior. The causal role of inflammation in development of
stress-induced depression was highlighted in the study by Wood et
al. (8), which demonstrated
that blocking interleukin-1β before stress had no effect on individual
differences in coping strategy but prevented individual differences in the
induction of depressive-like behavior. Furthermore, resilient animals displayed
anti-inflammatory responses to stress, consistent with a previously established
protective role of the acquired immune system (T cells) and anti-inflammatory
cytokines in promoting a shift toward an M2-like macrophage phenotype, reduced
inflammation in the brain, and prevention of stress-induced depression. IL,
interleukin.